These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity. Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297 [TBL] [Abstract][Full Text] [Related]
8. Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. Elango N; Coligan JE; Jambou RC; Venkatesan S J Virol; 1986 Feb; 57(2):481-9. PubMed ID: 3003381 [TBL] [Abstract][Full Text] [Related]
9. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3. Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317 [TBL] [Abstract][Full Text] [Related]
10. Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Blumberg B; Giorgi C; Roux L; Raju R; Dowling P; Chollet A; Kolakofsky D Cell; 1985 May; 41(1):269-78. PubMed ID: 2986845 [TBL] [Abstract][Full Text] [Related]
11. Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus. Krüger N; Hoffmann M; Drexler JF; Müller MA; Corman VM; Sauder C; Rubin S; He B; Örvell C; Drosten C; Herrler G J Virol; 2015 Apr; 89(8):4539-48. PubMed ID: 25741010 [TBL] [Abstract][Full Text] [Related]
12. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus. Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424 [TBL] [Abstract][Full Text] [Related]
13. Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983. van Wyke Coelingh KL; Winter CC; Murphy BR Virology; 1988 Jan; 162(1):137-43. PubMed ID: 2827373 [TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strains. Sato H; Hattori S; Ishida N; Imamura Y; Kawakita M Virus Res; 1987 Sep; 8(3):217-32. PubMed ID: 3687202 [TBL] [Abstract][Full Text] [Related]
17. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir). Murrell M; Porotto M; Weber T; Greengard O; Moscona A J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836 [TBL] [Abstract][Full Text] [Related]
18. Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin-neuraminidase glycoprotein. Reyes-Leyva J; Baños R; Borraz-Argüello M; Santos-López G; Rosas N; Alvarado G; Herrera I; Vallejo V; Tapia-Ramírez J Microbes Infect; 2007 Feb; 9(2):234-40. PubMed ID: 17223599 [TBL] [Abstract][Full Text] [Related]
19. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Merz DC; Wolinsky JS Virology; 1983 Dec; 131(2):328-40. PubMed ID: 6362184 [TBL] [Abstract][Full Text] [Related]
20. Identification of an amino acid that defines the fusogenicity of mumps virus. Tanabayashi K; Takeuchi K; Okazaki K; Hishiyama M; Yamada A J Virol; 1993 May; 67(5):2928-31. PubMed ID: 8474181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]